Serum Institute earlier said that its vaccine would cost Rs 400 per dose for state governments and Rs 600 per dose for private hospitals.
Bharat Biotech said that the vaccine not only had an excellent safety profile but it was formulated with adjuvants to improve immune response. Further, once opened, the vial could be kept at 2-8 degrees for 28 days, thus reducing wastage, it claimed.
The Phase-III clinical studies have shown that the vaccine has 78 per cent efficacy against Covid 19, and 100 per cent against a severe form of the disease. The company also noted that the manufacturing process was expensive due to low process yields, and that it was important to recover costs to invest in future R&D.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in